Michael Reusch, CMO at Guard Therapeutics, has been invited to participate as a faculty member in the 9th edition of the Kidney Disease Clinical Trialists Workshop (KDCT 2025), taking place at the Embassy of France in Washington, D.C., on April 4-5, 2025.